These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
174 related articles for article (PubMed ID: 819062)
1. [The type specific antigen of Gross leukemia virus in tumors and normal tissues and its identification by immunodiffusion methods]. Lezhneva OM Biull Eksp Biol Med; 1976 Feb; 81(2):217-9. PubMed ID: 819062 [TBL] [Abstract][Full Text] [Related]
2. [Expression of C-type oncornavirus proteins in tumors of CC57BR mice]. Bogovskii BP; Lezhneva OM Biull Eksp Biol Med; 1978 Mar; 85(3):334-7. PubMed ID: 78738 [TBL] [Abstract][Full Text] [Related]
3. AKR mouse leukemic cells in tissue culture. II. Immunologic studies on the AKR 87 cell line. Duś D; Harlozińska A; Skriabin A; Richter R Arch Immunol Ther Exp (Warsz); 1976; 24(5):727-40. PubMed ID: 187141 [TBL] [Abstract][Full Text] [Related]
4. The specificity of H-2-restricted cytotoxic T lymphocytes directed to AKR/Gross leukemia virus-induced tumors. III. Coordinate alterations in viral gp70 antigen expression and restoration of CTL-susceptibility to insusceptible variant tumors. Manjunath R; Graziano RF; Green WR J Immunol; 1986 Mar; 136(6):2271-9. PubMed ID: 3005407 [TBL] [Abstract][Full Text] [Related]
5. Cell surface expression of cytotoxic T lymphocyte-defined, AKR/Gross leukemia virus-associated tumor antigens by normal AKR.H-2b splenic B cells. Green WR J Immunol; 1983 Dec; 131(6):3078-84. PubMed ID: 6605998 [TBL] [Abstract][Full Text] [Related]
6. Genetic control of the induction of cytolytic T lymphocyte responses to AKR/Gross viral leukemias. I. H-2-encoded dominant gene control. Green WR J Immunol; 1984 May; 132(5):2658-64. PubMed ID: 6425409 [TBL] [Abstract][Full Text] [Related]
7. Clonal heterogeneity of anti-AKR/gross leukemia virus cytotoxic T lymphocytes. Evidence for two distinct antigen systems. Azuma H; Phillips JD; Green WR J Immunol; 1987 Oct; 139(7):2464-73. PubMed ID: 2821116 [TBL] [Abstract][Full Text] [Related]
8. Genetic control of the induction of cytolytic T lymphocyte responses to AKR/Gross viral leukemias. II. Negative control by the Fv-1 locus in AKR mice of responder H-2b haplotype. Green WR J Immunol; 1984 May; 132(5):2665-71. PubMed ID: 6425410 [TBL] [Abstract][Full Text] [Related]
9. The immune response to Moloney murine leukemia virus-induced tumors: induction of cytolytic T lymphocytes specific for both viral and tumor-associated antigens. Flyer DC; Burakoff SJ; Faller DV J Immunol; 1986 Dec; 137(12):3968-72. PubMed ID: 3491152 [TBL] [Abstract][Full Text] [Related]
10. Induction of gp70-specific suppressor T-cells in mice inoculated with virus-producing tumor cells. Bluestone JA; Lopez C J Natl Cancer Inst; 1982 Oct; 69(4):953-9. PubMed ID: 6214655 [TBL] [Abstract][Full Text] [Related]
11. In vivo antigenic modification of tumor cells. III. Metastatic thymic lymphoma specifically infected by thymotropic retrovirus. Iglehart JD; Weinhold KJ; Huper G; Thiel K; Bolognesi DP J Natl Cancer Inst; 1981 Jul; 67(1):123-30. PubMed ID: 6265678 [TBL] [Abstract][Full Text] [Related]
12. [Detection of antigens of endogenous viruses of the C-type during mouse development]. Bogovskiĭ BP; Lezhneva OM Biull Eksp Biol Med; 1977 Jul; 84(7):72-5. PubMed ID: 70247 [TBL] [Abstract][Full Text] [Related]
13. Heterogenization of normal tissues in oncogenesis. A skeptical review. Mariani T; Good RA Isr J Med Sci; 1973 Mar; 9(3):380-94. PubMed ID: 4575655 [No Abstract] [Full Text] [Related]
14. Immune complexes localized in the renal glomeruli of AKR mice: the presence of MuLV gs-I and C-type RNA tumor virus gs-3 determinants. Markham RV; Sutherland JC; Cimino EF; Drake WP; Mardiney MR Rev Eur Etud Clin Biol; 1972; 17(7):690-4. PubMed ID: 4119502 [No Abstract] [Full Text] [Related]
15. Antigens of tumours induced by naturally occurring murine sarcoma virus (MSV-FBJ). I. Detection of group and type specific antigens by complement fixation. Jones DB; Moore M Br J Cancer; 1974 Jan; 29(1):21-30. PubMed ID: 4820943 [TBL] [Abstract][Full Text] [Related]
16. Identification of a viral antigen recognized by H-2-restricted cytolytic T lymphocytes on a murine leukemia virus-induced tumor. Plata F; Kalil J; Zilber MT; Fellous M; Lévy D J Immunol; 1983 Nov; 131(5):2551-6. PubMed ID: 6605389 [TBL] [Abstract][Full Text] [Related]
17. Increase in Gross (G) antigen sites on the surface of AKR virus-induced rat lymphoma cells after treatment with trypsin. Brandchaft PB; Boone CW J Immunol; 1974 Jul; 113(1):94-102. PubMed ID: 4364955 [No Abstract] [Full Text] [Related]
18. Expression of CTL-defined, AKR/Gross retrovirus-associated tumor antigens by normal spleen cells: control by Fv-1, H-2, and proviral genes and effect on antiviral CTL generation. Green WR J Immunol; 1986 Jan; 136(1):308-12. PubMed ID: 2999246 [TBL] [Abstract][Full Text] [Related]
19. Presence of complement-fixing antibodies against antigens of Gross virus-induced rat lymphoma and normal rat thymus in sera of patients with some forms of malignancies. Simkovic D; Chorváth B; Hlubinová K; Valentová N; Stevonková J; Babusíková O; Simkovicová M Neoplasma; 1977; 24(4):357-63. PubMed ID: 269322 [TBL] [Abstract][Full Text] [Related]
20. Mechanism of nonresponsiveness to AKR/Gross leukemia virus in AKR.H-2b:Fv-1b mice. An analysis of precursor cytotoxic T lymphocyte frequencies in young versus moderately aged mice. Wegmann KW; McMaster JS; Green WR J Immunol; 1991 Apr; 146(7):2469-77. PubMed ID: 2005406 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]